New agreement seeks to speed up UK research

February 25, 2011
Research and Development BIA, Industry Collaborative Research Agreement, MRC, Medical Research Council, National Institute for Health Research, Office for Clinical Research Infrastructure, UK research, clinical research, mICRA

The government has revised the research contracting process in a bid to streamline research between pharma and biotech companies, universities …

Pfizer research Sandwich, Kent

MPs to question Pfizer management over R&D closure

February 25, 2011
Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee, research and development

Senior Pfizer executives will appear before MPs next week to answer questions on the closure of the company’s Kent research …

caroline_gosling_virgo_vantage

Virgo Health boosts consultancy team

February 25, 2011
Medical Communications Caroline Gosling, Vantage, Virgo, Virgo Health PR, appointment, medical communications

Former Virgo Health PR managing director Caroline Gosling has moved to the company’s consultancy arm Vantage. She takes on a …

Sanofi picks two agencies for UK diabetes account

February 25, 2011
Medical Communications Lantus, Sanofi-Aventis, Tudor Reilly, diabetes, medical communications account win, red health

Healthcare PR agencies Tudor Reilly and Red Health have jointly won the Sanofi-Aventis UK diabetes account after a five-way pitch. …

Cally Clarkson joins HealthEd

February 25, 2011
Medical Communications Cally Clarkson, HealthEd, appointment, medical communications

Cheshire, UK-based medical education agency HealthEd has appointed Cally Clarkson as client services director. She has 10 years of healthcare …

MedImmune

Retaining pharma top talent

February 25, 2011
Business Services MedImmune, careers, recruitment, talent retention

Strategies to co-ordinate talent retention differ between companies, and they may not always be as forward-focused as they could – …

Glioblastoma vaccine enters phase II

February 24, 2011
Research and Development Cancer, GBM, ImmunoCellular Therapeutics, oncology

The first patient has been enrolled in a phase II trial of ICT-107, a cancer vaccine candidate for the treatment …

Blog footer

Digital Pharma: Sanofi shifts video focus to YouTube

February 24, 2011
Medical Communications Digital Pharma blog, Sanofi-Aventis, online pharma video, youtube

Sanofi-Aventis has scaled back its online video ambitions and moved its web TV channel to YouTube. The move sees the …

Working Life: BMS UK’s market access director Patrick Hopkinson

February 24, 2011
Business Services, Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, Patrick Hopkinson, Working Life, recruitment

Patrick Hopkinson, director of market access and external affairs at Bristol-Myers Squibb UK, talks to Pharmafocus about how he got …

astrallas_minesh_ghelani

Minesh Ghelani joins Astralis Group

February 24, 2011
Business Services Astralis Group, Mishesh Ghelani, appointment, business services

Recruitment consultancy Astralis has appointed Minesh Ghelani as a senior consultant to its Life Sciences Practice.After obtaining his degree in …

Abbott's Humira (adalimumab)

Abbott wins $1.7bn Humira case

February 24, 2011
Sales and Marketing Abbott, Abbott Laboratories, Centocor, Johnson and Johnson, Remicade, Simponi, TNF, golimumab, infliximab, rheumatoid arthritis

Abbott has been saved from paying Johnson & Johnson $1.7 billion after a US appeals court quashed a patent dispute …

50,000 NHS jobs to be cut

February 24, 2011
False Economy, GPs, NHS, NHS reforms, TUC, nurses

NHS trusts are preparing to make a major series of job cuts as the health service wrestles with the need …

Red Door boosts management team

February 24, 2011
Medical Communications Laura Clark, Liz Adams, Red Door Communications, appointment, medical communications

Red Door Communications has appointed its first `home grown’ consultant to its management team. Laura Clark has been made an …

Roche building

Roche pulls out of vaccine alliance with Transgene

February 23, 2011
Research and Development HPV, HPV vaccine, Roche, TG4001, Transgene, cervical cancer, cervical lesions, human papilloma virus, vaccines

Roche has terminated its license agreement with Transgene for its HPV therapeutic vaccine TG4001. The vaccine is currently being tested …

Online international research register launched

February 23, 2011
Research and Development CRD, Centre for Reviews and Dissemination, Department of Health, NIHR, National Institute for Health Research, Prospero, clinical research, health research register

The UK government has backed the creation of a free, international online register to improve the transparency of health research. …

Lung cancer cells

No magic bullet, but a growing arsenal against lung cancer

February 23, 2011
Research and Development ASA404, Cancer, Iressa, NSCLC, Tarceva, afatinib, crizotinib, figitumumab, lung cancer, non small cell lung cancer, non-small cell lung cancer

A man in his 70s is waiting for his appointment with the oncologist after being referred there by his family …

J&J hepatitis C drug begins phase III trials

February 23, 2011
Research and Development J&J, JJ, Johnson and Johnson, TMC435, Tibotec, hepatitis, hepatitis C

Johnson & Johnson has begun late stage trials of hepatitis C drug TMC435 as a first line treatment for the …

Roche's Avastin (bevacizumab)

NICE yes for Votrient, no to Avastin

February 23, 2011
Sales and Marketing Cancer, GSK, GlaxoSmithKline, Kidney cancer, NICE, Roche, avastin, bevacizumab, breast cancer

NICE has recommended GlaxoSmithKline’s kidney cancer drug Votrient on the same day it gave a final negative decision to Roche’s …

Commissioning Board to spearhead NHS reforms

February 23, 2011
GP consortia, Health and Social Care Bill, NHS, NHS Commissioning Board, NHS reforms, PCT clusters, PCTs, SHAs, Sir David Nicholson, pathfinder consortia

NHS chief executive Sir David Nicholson says the new NHS Commissioning Board will be the driving force behind the health …

ge_healthcare_kieran_murphy

Kieran Murphy to head up life sciences for GE Healthcare

February 23, 2011
Research and Development, Sales and Marketing GE Healthcare, Kieran Murphy, appointment, research and development, sales and marketing

GE Healthcare has promoted Kieran Murphy to succeed its current Life Sciences president and chief executive Peter Ehrenheim. Kieran, who …

The Gateway to Local Adoption Series

Latest content